Centene Corp Files 8-K: Regulation FD Disclosure

Ticker: CNC · Form: 8-K · Filed: 2025-05-06T00:00:00.000Z

Sentiment: neutral

Topics: 8-K, Regulation FD, disclosure

Related Tickers: CNC

TL;DR

Centene filed an 8-K, likely a Reg FD disclosure. Watch for updates.

AI Summary

Centene Corporation filed an 8-K on May 6, 2025, reporting an event that occurred on May 5, 2025. The filing is categorized under Regulation FD Disclosure, indicating it pertains to material information that could affect investor decisions. No specific financial transactions or operational changes were detailed in the provided excerpt.

Why It Matters

This filing signals Centene Corporation is disclosing material information to the public, which could impact investor understanding of the company's current status.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for Regulation FD disclosure, with no immediate indication of negative events or significant financial changes.

Key Players & Entities

FAQ

What specific event triggered this Regulation FD Disclosure filing by Centene Corporation?

The provided excerpt does not specify the exact event that triggered the Regulation FD Disclosure filing, only that it was reported on May 6, 2025, and the earliest event was on May 5, 2025.

What is the significance of a 'Regulation FD Disclosure' filing?

A Regulation FD Disclosure filing means Centene Corporation is publicly disseminating material information that could affect investor decisions, ensuring fair disclosure to all investors.

What is Centene Corporation's principal executive office address?

Centene Corporation's principal executive offices are located at 7700 Forsyth Boulevard, St. Louis, Missouri 63105.

What is the SEC file number for Centene Corporation?

Centene Corporation's SEC file number is 001-31826.

What is the IRS Employer Identification Number (EIN) for Centene Corporation?

Centene Corporation's IRS Employer Identification Number (EIN) is 42-1406317.

From the Filing

0001071739-25-000092.txt : 20250506 0001071739-25-000092.hdr.sgml : 20250506 20250505210553 ACCESSION NUMBER: 0001071739-25-000092 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20250506 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20250506 DATE AS OF CHANGE: 20250505 FILER: COMPANY DATA: COMPANY CONFORMED NAME: CENTENE CORP CENTRAL INDEX KEY: 0001071739 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 041406317 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-31826 FILM NUMBER: 25914823 BUSINESS ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 BUSINESS PHONE: 3147254477 MAIL ADDRESS: STREET 1: 7700 FORSYTH BLVD. CITY: ST LOUIS STATE: MO ZIP: 63105 8-K 1 cnc-20250506.htm 8-K cnc-20250506 0001071739 false 0001071739 2025-05-06 2025-05-06 UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 6, 2025 CENTENE CORPORATION (Exact Name of Registrant as Specified in Charter) Delaware 001-31826 42-1406317 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) 7700 Forsyth Boulevard, St. Louis, Missouri 63105 (Address of Principal Executive Offices) (Zip Code) Registrant's telephone number, including area code: ( 314 ) 725-4477 (Former Name or Former Address, if Changed Since Last Report): N/A Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): ☐      Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐      Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐      Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐      Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common stock, $0.001 Par Value CNC New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).   Emerging growth company  ☐   If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐ ITEM 7.01 REGULATION FD DISCLOSURE On May 6, 2025, members of Centene Corporation's (the Company's) senior management team will meet with investors. Consistent with the Company's guidance previously provided on April 25, 2025, the senior management team plans to reaffirm the Company's 2025 full year GAAP diluted earnings per share (EPS) guidance floor of greater than $6.19 and its full year adjusted diluted EPS guidance floor of greater than $7.25. Non-GAAP Financial Presentation The Company is providing certain non-GAAP financial measures in this Form 8-K as the Company believes that these figures are helpful in allowing investors to more accurately assess the ongoing nature of the Company's operations and measure the Company's performance more consistently across periods. The Company uses the presented non-GAAP financial measures internally in evaluating the Company's p

View on Read The Filing